Keros Therapeutics (KROS) Q2 2025 Earnings

May 6Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.41
0.27
1.94
3.62

Details

Expected EPS
-1.153528
Actual EPS
3.62
Surprise EPS
4.77
Surprise Percent
+413.82%

Description

⁨Keros Therapeutics⁩ (⁦KROS⁩) has reported earnings of ⁦3.62⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts